DK277788D0 - Linaere og cycliske alfa-melanotropinanaloge - Google Patents

Linaere og cycliske alfa-melanotropinanaloge

Info

Publication number
DK277788D0
DK277788D0 DK277788A DK277788A DK277788D0 DK 277788 D0 DK277788 D0 DK 277788D0 DK 277788 A DK277788 A DK 277788A DK 277788 A DK277788 A DK 277788A DK 277788 D0 DK277788 D0 DK 277788D0
Authority
DK
Denmark
Prior art keywords
linear
cyclic
alfa
analogues
melanotropin analogue
Prior art date
Application number
DK277788A
Other languages
English (en)
Other versions
DK277788A (da
DK172760B1 (da
Inventor
Victor J Hruby
Fahad A Ol-Obeidi
Mac E Hadley
Original Assignee
University Patents Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Patents Inc filed Critical University Patents Inc
Publication of DK277788D0 publication Critical patent/DK277788D0/da
Publication of DK277788A publication Critical patent/DK277788A/da
Application granted granted Critical
Publication of DK172760B1 publication Critical patent/DK172760B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/68—Melanocyte-stimulating hormone [MSH]
    • C07K14/685—Alpha-melanotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Cosmetics (AREA)
  • Saccharide Compounds (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
DK198802777A 1987-05-22 1988-05-20 Lineære og cycliske analoge til alfa-MSH-fragmenter med ekstraordinær styrke, lægemiddel eller kosmetisk præparat indeholde DK172760B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US5322987A 1987-05-22 1987-05-22
US5322987 1987-05-22
CA000578920A CA1340107C (en) 1987-05-22 1988-09-30 Linear and cyclic analoques of alpha-msh fragments with extraordinary potency
CA578920 1988-09-30

Publications (3)

Publication Number Publication Date
DK277788D0 true DK277788D0 (da) 1988-05-20
DK277788A DK277788A (da) 1988-11-23
DK172760B1 DK172760B1 (da) 1999-06-28

Family

ID=25672150

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198802777A DK172760B1 (da) 1987-05-22 1988-05-20 Lineære og cycliske analoge til alfa-MSH-fragmenter med ekstraordinær styrke, lægemiddel eller kosmetisk præparat indeholde

Country Status (11)

Country Link
EP (1) EP0292291B1 (da)
JP (1) JPH0826077B2 (da)
CN (1) CN1031242C (da)
AT (1) ATE109793T1 (da)
CA (1) CA1340107C (da)
DE (1) DE3851002T2 (da)
DK (1) DK172760B1 (da)
FI (1) FI882380A7 (da)
IE (1) IE64903B1 (da)
PH (1) PH25819A (da)
PT (1) PT87560B (da)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5674839A (en) * 1987-05-22 1997-10-07 Competitive Technologies, Inc. Cyclic analogs of alpha-MSH fragments
US5683981A (en) * 1987-05-22 1997-11-04 Competitive Technologies, Inc. Cyclic bridged analogs of α-MSH and methods thereof
EP0389950A1 (en) * 1989-03-23 1990-10-03 Lion Corporation Melanocyte-stimulating hormone inhibitor and external preparation containing the same
US5071583A (en) * 1990-08-14 1991-12-10 Steve Martell Soap bar having a fifth finger gripping member
GB9102450D0 (en) * 1991-02-05 1991-03-20 Sandoz Ltd Improvements in or relating to organic compounds
US5364851A (en) * 1991-06-14 1994-11-15 International Synthecon, Llc Conformationally restricted biologically active peptides, methods for their production and uses thereof
US6100048A (en) * 1992-04-10 2000-08-08 Oregon Health Sciences University Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals
FR2691465B1 (fr) * 1992-05-25 1995-08-11 Pf Medicament Complexes comprenant au moins un peptide derive de l'alpha msh, peptide, microsphere, medicament et composition galenique les comprenant.
WO1994022460A1 (en) * 1993-04-05 1994-10-13 University Patents, Inc. Diagnosis and treatment of erectile dysfunction
FR2710340B1 (fr) * 1993-09-22 1995-12-15 D Hinterland Lucien Dussourd Dérivés peptidiques de l'alpha-MSH et leur application .
US5726156A (en) * 1995-03-06 1998-03-10 Trega Biosciences, Inc. Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels
US5786332A (en) * 1995-03-06 1998-07-28 Trega Biosciences, Inc. Cytokine restraining agents and methods of use in pathologies and conditions associated with altered cytokine levels
US5420109A (en) * 1993-11-12 1995-05-30 Houghten Pharmaceuticals, Inc. Cytokine restraining agents
US6716810B1 (en) * 1998-12-09 2004-04-06 Eleanor Roosevelt Institute Composition and method for regulation of body weight and associated conditions
DK1165613T3 (da) 1999-03-29 2008-08-25 Procter & Gamble Melanocortinreceptorligander
TW200718944A (en) * 1999-06-29 2007-05-16 Univ New York Screening methods for compounds that affect melanogenesis
DE10228837B4 (de) * 2002-06-27 2016-01-07 Elfriede Rauch Hautkosmetische Zusammensetzung und Verwendung der Zusammensetzung als Hautbräunungsmittel
EP1670815A2 (en) 2003-09-30 2006-06-21 Novo Nordisk A/S Melanocortin receptor agonists
EP1812034A4 (en) * 2004-10-08 2009-07-29 Clinuvel Pharmaceuticals Ltd COMPOSITIONS AND METHODS OF INDUCING MELANOESEES IN ONE PERSON
CN100355776C (zh) * 2005-06-20 2007-12-19 中国人民解放军第二军医大学 一种新型α－黑素细胞刺激素类似物及其用途
JP2009500426A (ja) 2005-07-08 2009-01-08 ソシエテ・ドゥ・コンセイユ・ドゥ・ルシェルシュ・エ・ダプリカーション・シャンティフィック・エス・ア・エス メラノコルチン受容体のリガンド
WO2009118191A2 (en) 2008-03-27 2009-10-01 Clinuvel Pharmaceuticals Limited Therapy for vitiligo
KR101687037B1 (ko) 2008-06-09 2016-12-15 팔라틴 테크놀로지스 인코포레이티드 성기능 장애 치료용 멜라노코르틴 수용체-특이적 펩티드
EP2350031A2 (en) 2008-08-20 2011-08-03 Ensemble Therapeutics Corporation Macrocyclic compounds for inhibition of tumor necrosis factor alpha
UY32690A (es) 2009-06-08 2011-01-31 Astrazeneca Ab Péptidos específicos para receptores de melanocortina
JP2013511554A (ja) 2009-11-23 2013-04-04 パラティン テクノロジーズ，インコーポレイテッド メラノコルチン−１受容体特異的線状ペプチド
WO2011063366A1 (en) 2009-11-23 2011-05-26 Palatin Technologies, Inc. Melanocortin-1 receptor-specific cyclic peptides
CN102816211B (zh) * 2012-09-10 2014-07-23 南京工业大学 一种制备美那诺坦的方法
RU2020120797A (ru) 2013-03-15 2020-07-02 Ритм Фармасьютикалз, Инк. Пептидные композиции

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US448539A (en) 1891-03-17 Cornelius s morris
US4457864A (en) * 1981-10-23 1984-07-03 University Patents, Inc. Synthetic analogues of α-melanotropin
US4485039A (en) * 1982-06-11 1984-11-27 University Patents, Inc. Synthetic analogues of α-melanotropin

Also Published As

Publication number Publication date
IE881537L (en) 1988-11-22
DE3851002D1 (de) 1994-09-15
EP0292291A3 (en) 1990-05-02
PH25819A (en) 1991-11-05
CN1031242C (zh) 1996-03-13
JPS6470499A (en) 1989-03-15
DE3851002T2 (de) 1995-02-02
PT87560A (pt) 1989-05-31
DK277788A (da) 1988-11-23
AU1650688A (en) 1988-11-24
EP0292291A2 (en) 1988-11-23
FI882380A7 (fi) 1988-11-23
CA1340107C (en) 1998-10-27
IE64903B1 (en) 1995-09-20
PT87560B (pt) 1992-09-30
DK172760B1 (da) 1999-06-28
EP0292291B1 (en) 1994-08-10
AU618733B2 (en) 1992-01-09
ATE109793T1 (de) 1994-08-15
CN1032795A (zh) 1989-05-10
FI882380A0 (fi) 1988-05-20
JPH0826077B2 (ja) 1996-03-13

Similar Documents

Publication Publication Date Title
DK277788A (da) Linaere og cycliske alfa-melanotropinanaloge
LV10588A (lv) Rotalu zobstiena dzelzcels
KR880700670A (ko) 알파-msh의 동족체의 국소적용으로 메라노싸이트를 자극시키는 방법 및 이에 사용될 수 있는 조성물
FI884221A7 (fi) Kovettuva silikonikoostumus
DE69214005D1 (de) Erhärtende Zusammensetzungen zur Verwendung in der Medizin oder Zahnheilkunde
NO861955L (no) Hydrolyserbar harpiksblanding og et antibegroningsbelegg inneholdende dette:
DE3784447D1 (de) Haertbare organopolysiloxanzusammensetzung.
FR2599186B1 (fr) Manipulateur analogique
DK49488D0 (da) Anaestesi-praeparat
DK627687D0 (da) Hirudinvariant
IT8547748A0 (it) Compressore di tipo chiuso e metodo per assemblarlo
KR890700146A (ko) 일액 경화 조성물
DK539587D0 (da) Faktor viii-c analoge
FI880416L (fi) Puun käsittelyseos ja -menetelmä
FI910795A0 (fi) 0-glykocylerad ifg-1.
ATE76579T1 (de) Interferon-zusammensetzungen.
ATE45675T1 (de) Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen.
FI873408A7 (fi) Anesteettinen koostumus ja menetelmä sen käyttämiseksi.
IT7848845A0 (it) Processo per indurire ed usare composizioni resinose furan-formaldeidiche e relative composizioni induribili
IT1186767B (it) Composizione disinfettante per via aerea
DE3674997D1 (de) Holzbehandlungszusammensetzung.
DE3855878D1 (de) Sauerstoffanalysegerät
ATE87314T1 (de) Platin-arzneimittel.
MY104115A (en) Linear and cyclic analogs of alpha-msh fragments with extraordinary potency
NO930628D0 (no) Fenolterminert diestersammensetning og herdbare sammensetninger inneholdende denne

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired